Roche Innovation Center Copenhagen A/S is the home of RNA Therapeutics Research (RTR) for Roche Pharma Research and Early Development (pRED) and is a leader in the rapidly emerging field of RNA-targeted drugs, where it is exploiting its proprietary Locked Nucleic Acid (LNA) platform to discover important novel medicines across multiple therapeutic areas.